ALTERITY THERAPEUTICS LTD (ATHE) Form 6-K — Aug 28, 2026

Alterity Therapeutics Limited filed a Form 6-K on August 28, 2026 containing its completed ASX Appendix 4G, the key to its corporate governance disclosures for the financial year ended June 30, 2026. The filing confirms the board approved the corporate governance statement as accurate and up to date as of August 28, 2026, with the full statement and supporting policies (board charter, code of conduct, whistleblower and anti-bribery policies) posted at alteritytx.com/governance. The company discloses it does not have a nomination committee and does not have an internal audit function, with its reasons and alternative processes set out in the corporate governance statement.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.